PFunding Rounds · Post-IPO
Pangaea Oncology — Post-IPO · approximately €2.93M
The board approved a capital increase of up to about €4.7M in December 2025. When it closed on 26 February 2026, it had raised about €2.935M through 1,778,796 new shares, and it was registered on 12 March 2026. The raise strengthened the balance sheet and added free float on BME Growth; no subscribers were named.
Lead unknown
RoundPost-IPO
Announced26 Feb 2026Not counted in totals
CityBarcelona
SectorHealthtech / Precision oncologySource
E
E
The company
Investors
No investors were disclosed for this round.